Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chung-Hwan Gwak, MD, PhD
Gyeongsang National University Hospital
Study Director - Ki-Bae Seung, MD, PhD
Seoul St. Mary's Hospital
Study Director - Kwon-Sam Kim, MD,PhD
Kyung Hee University Hospital
Study Director - Sang-Hyun Kim, MD,PhD
Seoul Metropolitan Boramae Hospital
Study Director - Seung-Jae Joo, MD,PhD
Jeju National University Hospital
Study Director - Seung-Jea Tahk, MD,PhD
Ajou University Medical Center
Study Director - Soon-Jun Hong, MD,PhD
Korea University Anam Hospital
Study Director - Tae-Ho Park, MD,PhD
Dong-A medical center
Study Director - Young-Jin Choi, MD,PhD
Hallym University Medical Center
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2013
- Primary completion
- 31 Oct 2016
- Completion
- 31 Oct 2016
- Last update posted
- 13 Oct 2016
- Registered enrollment
- 306
- Registry id
- NCT00947843
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.